2025
SJR Q3
JCR Q4 · 1,5
13 eşleşen makale
SCIE
Dergi ayrıntısı
Xenobiotica
- Yayıncı
- Taylor and Francis Ltd.
- Ülke
- United Kingdom · Western Europe
- Tür
- journal
- ISSN
-
0049825413665928
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 0,381
- Quartile Q3
- H-Index 95
- Atıf/yayın 1,62
- Doküman (3y) 252
- Atıf (3y) 368
Clarivate
Web of Science · JCR · 2025
- JCR Q Q4
- JIF 1,5
- 5Y JIF 1,4
- JCI 0,39
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Biochemistry Q3
- Health, Toxicology and Mutagenesis Q3
- Medicine (miscellaneous) Q3
- Pharmacology Q3
- Toxicology Q3
Alanlar
- Biochemistry, Genetics and Molecular Biology
- Environmental Science
- Medicine
- Pharmacology, Toxicology and Pharmaceutics
WoS kategorileri
- Pharmacology & Pharmacy | Toxicology
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q3 | Q4 | 0,381 | 1,5 | 1,4 | 0,39 | Q4 | 95 |
| 2024 | Q3 | Q4 | 0,348 | 1,2 | 1,3 | 0,38 | Q4 | 91 |
| 2023 | Q3 | Q4 | 0,387 | 1,3 | 1,4 | 0,42 | Q3 | 91 |
| 2022 | Q3 | Q4 | 0,42 | 1,8 | 1,6 | 0,49 | Q3 | 91 |
| 2021 | Q3 | Q4 | 0,403 | 2 | 1,8 | 0,52 | Q3 | 91 |
| 2020 | Q3 | Q4 | 0,465 | 1,9 | 1,9 | 0,67 | Q3 | 91 |
| 2019 | Q2 | Q3 | 0,514 | 1,9 | 1,7 | 0,69 | Q2 | 91 |
| 2018 | — | Q3 | — | 1,9 | 1,7 | 0,68 | Q3 | — |
| 2017 | Q2 | Q3 | 0,47 | 1,9 | 1,7 | 0,71 | Q2 | 91 |
| 2016 | Q2 | Q3 | 0,492 | 1,9 | 1,8 | — | — | 91 |
| 2015 | Q2 | Q3 | 0,607 | 1,7 | 1,8 | — | — | 91 |
| 2014 | Q2 | Q3 | 0,681 | 2,2 | 2 | — | — | 91 |
| 2013 | Q2 | Q3 | 0,71 | 2,1 | 2,2 | — | — | 91 |
| 2012 | Q2 | Q3 | 0,723 | 2 | 2,3 | — | — | 91 |
| 2011 | Q1 | Q3 | 0,85 | 1,8 | 2,4 | — | — | 91 |
| 2010 | Q1 | Q2 | 0,881 | 2,7 | 2,4 | — | — | 91 |
| 2009 | — | Q2 | — | 2,8 | 2,4 | — | — | — |
| 2008 | — | Q3 | — | 1,9 | 1,9 | — | — | — |
| 2007 | — | Q2 | — | 2 | 1,9 | — | — | — |
| 2006 | — | Q3 | — | 1,6 | — | — | — | — |
| 2005 | — | Q3 | — | 1,4 | — | — | — | — |
| 2004 | — | Q2 | — | 1,8 | — | — | — | — |
| 2003 | — | Q1 | — | 2,2 | — | — | — | — |
| 2002 | — | Q2 | — | 1,9 | — | — | — | — |
| 2001 | — | Q1 | — | 1,9 | — | — | — | — |
| 2000 | — | Q1 | — | 2 | — | — | — | — |
| 1999 | — | Q2 | — | 1,3 | — | — | — | — |
| 1998 | — | Q2 | — | 1,5 | — | — | — | — |
| 1997 | — | Q2 | — | 1,5 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 286/356 |
| 2025 | TOXICOLOGY | SCIE | Q4 | Q4 | 98/106 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 291/352 |
| 2024 | TOXICOLOGY | SCIE | Q4 | Q4 | 98/106 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 283/354 |
| 2023 | TOXICOLOGY | SCIE | Q4 | Q4 | 96/106 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 231/278 |
| 2022 | TOXICOLOGY | SCIE | Q4 | Q4 | 86/94 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 234/279 |
| 2021 | TOXICOLOGY | SCIE | Q4 | Q4 | 84/94 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 227/276 |
| 2020 | TOXICOLOGY | SCIE | Q4 | Q3 | 85/93 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 203/271 |
| 2019 | TOXICOLOGY | SCIE | Q4 | Q3 | 73/92 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 188/267 |
| 2018 | TOXICOLOGY | SCIE | Q4 | Q3 | 72/93 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 189/261 |
| 2017 | TOXICOLOGY | SCIE | Q3 | Q3 | 69/94 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 168/257 |
| 2016 | TOXICOLOGY | SCIE | Q3 | — | 63/92 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 172/255 |
| 2015 | TOXICOLOGY | SCIE | Q3 | — | 65/90 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 134/255 |
| 2014 | TOXICOLOGY | SCIE | Q3 | — | 50/88 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 144/256 |
| 2013 | TOXICOLOGY | SCIE | Q3 | — | 51/87 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 154/261 |
| 2012 | TOXICOLOGY | SCIE | Q3 | — | 56/85 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 157/261 |
| 2011 | TOXICOLOGY | SCIE | Q3 | — | 58/83 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 94/252 |
| 2010 | TOXICOLOGY | SCIE | Q2 | — | 30/83 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 87/237 |
| 2009 | TOXICOLOGY | SCIE | Q2 | — | 25/77 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 130/219 |
| 2008 | TOXICOLOGY | SCIE | Q3 | — | 44/75 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 112/205 |
| 2007 | TOXICOLOGY | SCIE | Q2 | — | 33/73 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 120/199 |
| 2006 | TOXICOLOGY | SCIE | Q3 | — | 47/76 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 122/193 |
| 2005 | TOXICOLOGY | SCIE | Q3 | — | 50/75 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 96/187 |
| 2004 | TOXICOLOGY | SCIE | Q2 | — | 30/75 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 64/185 |
| 2003 | TOXICOLOGY | SCIE | Q1 | — | 15/77 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 70/188 |
| 2002 | TOXICOLOGY | SCIE | Q2 | — | 20/76 |
| 2001 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 156/308 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 61/186 |
| 2001 | TOXICOLOGY | SCIE | Q1 | — | 19/78 |
| 2000 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 149/310 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 56/181 |
| 2000 | TOXICOLOGY | SCIE | Q1 | — | 17/77 |
| 1999 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 182/295 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 78/175 |
| 1999 | TOXICOLOGY | SCIE | Q2 | — | 29/74 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 68/178 |
| 1998 | TOXICOLOGY | SCIE | Q2 | — | 20/71 |
| 1997 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 62/157 |
| 1997 | TOXICOLOGY | SCIE | Q2 | — | 17/63 |